Abacus Medicine Pharmaceuticals ApS: Financial statements 2023
CVR: 39192063
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Abacus Medicine Pharmaceuticals ApS (CVR 39192063) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -72,855 and a net result of DKK 1,385,541 compared with DKK -4,553,460 the year before. Equity in the 2023 report amounted to DKK 22,182,951. The solvency ratio was 17.4%.
- Gross Profit
- DKK -72,855
- Profit/Loss
- DKK 1,385,541
- Equity
- DKK 22,182,951
- Total Assets
- DKK 127,181,357
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -73K | 1.4M | 22.2M | 0 |
| 2022 | - | -36K | -4.6M | 20.8M | 0 |
| 2021 | - | -43K | 2.8M | 25.4M | 0 |
| 2020 | - | -63K | 188K | 22.6M | 0 |
| 2019 | - | -212K | 548K | 15.9M | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Abacus Medicine Pharmaceuticals ApS has published its annual report for 2022. Gross profit came to DKK -36,339, and the net result was DKK -4,553,460.
About Abacus Medicine Pharmaceuticals ApS
Abacus Medicine Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2017. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Abacus Medicine Pharma Services ApS and Aposave ApS. The management consists of Flemming Wagner. The company is owned by ABACUS MEDICINE A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -80,000 and a net result of DKK -5,483,000 compared with DKK -2,436,000 the year before. Equity in the 2025 report amounted to DKK 14,264,000.